The most promising GLP-1R agonist in terms of efficacy, adverse effects, convenience for patients, cost-effectiveness and risk of cardiovascular complications is semaglutide, which is the only GLP-1R agonist that can be administrated as both an oral and injectable formulation
Saatman KE, Contreras PC, Smith DH, Raghupathi R, McDermott KL, Fernandez SC, et al
GHRP-6 is a hexapeptide GHS-R1a agonist (MW 873.01 Da) with broader receptor activity that increases GH, cortisol, prolactin, and appetite (ghrelin-like)
The recent advances in molecular diagnosis of soft tissue tumors
Tendon and Connective Tissue Research Animal-based tendon and ligament studies hypothesize that BPC-157 may enhance cellular migration and survival under stress conditions
Spracklen CN, Horikoshi M, Kim YJ, Lin K, Bragg F, Moon S, et al